A key role of microRNA-29b in suppression of osteosarcoma cell proliferation and migration via modulation of VEGF

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 9, 2014, Pages 5701-5708

  Zhang, Kexiang ^a   Zhang, Chaoyue ^a   Liu, Li ^a   Zhou, Jiahui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Micro RNA; miR 29b; Osteosarcoma; Vascular endothelial growth factor

Indexed keywords

MICRORNA; MIRN29 MICRORNA, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

APOPTOSIS; BONE TUMOR; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; OSTEOSARCOMA; PATHOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; OSTEOSARCOMA; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84911483104     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vijayamurugan N, Bakhshi S. Review of management issues in relapsed osteosarcoma. Expert Rev Anticancer Ther 2014; 14: 151-161.
2. Farcas N, Arzi B, Verstraete FJ. Oral and maxillofacial osteosarcoma in dogs: A review. Vet Comp Oncol 2012; [Epub ahead of print].
3. van den Berg H, Schreuder WH, de Lange J. Osteosarcoma: A comparison of jaw versus nonjaw localizations and review of the literature. Sarcoma 2013; 2013: 316123.
4. Abbo O, Pinnagoda K, Micol LA, Beck Popovic M, Joseph JM. Osteosarcoma metastasis causing ileo-ileal intussusception. World J Surg Oncol 2013; 11: 188.
5. Sun K, Lai EC. Adultspecific functions of animal micrornas. Nat Rev Genet 2013; 14: 535-548.
6. Hulsmans M, Holvoet P. Micrornacontaining microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res 2013; 100: 7-18.
7. Swaminathan S, Murray DD, Kelleher AD. Mirnas and hiv: Unforeseen determinants of host-pathogen interaction. Immunol Rev 2013; 254: 265-280.
8. Hodzic J, Giovannetti E, Diosdado B, Adema AD, Peters GJ. Regulation of deoxycytidine kinase expression and sensitivity to gemcitabine by microrna 330 and promoter methylation in cancer cells. Nucleosides Nucleotides Nucleic Acids 2011; 30: 1214-1222.
9. Zhang Y, Ghazwani M, Li J, Sun M, Stolz DB, He F, Fan J, Xie W, Li S. Mir-29b inhibits collagen maturation in hepatic stellate cells through downregulating the expression of hsp47 and lysyl oxidase. Biochem Biophys Res Commun 2014; 446: 940-4.
10. Chen B, Li H, Zeng X, Yang P, Liu X, Zhao X, Liang S. Roles of microrna on cancer cell metabolism. J Transl Med 2012; 10: 228.
11. Kwiecinski M, Elfimova N, Noetel A, Tox U, Steffen HM, Hacker U, Nischt R, Dienes HP, Odenthal M. Expression of plateletderived growth factorc and insulin-like growth factor i in hepatic stellate cells is inhibited by mir-29. Lab Invest 2012; 92: 978-987.
12. Dai N, Zhong ZY, Cun YP, Qing Y, Chen C, Jiang P, Li MX, Wang D. Alteration of the microrna expression profile in human osteosarcoma cells transfected with ape1 sirna. Neoplasma 2013; 60: 384-394.
13. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan R. Mirna signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 2012; 72: 1865-1877.
14. Zhou Y, Huang Z, Wu S, Zang X, Liu M, Shi J. Mir-33a is upregulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by downregulating twist. J Exp Clin Cancer Res 2014; 33: 12.
15. Kobayashi E, Satow R, Ono M, Masuda M, Honda K, Sakuma T, Kawai A, Morioka H, Toyama Y, Yamada T. Microrna expression and functional profiles of osteosarcoma. Oncology 2014; 86: 94-103.
16. Jiang H, Zhang G, Wu JH, Jiang CP. Diverse roles of mir-29 in cancer (review). Oncol Rep 2014; 31: 1509-1516.
17. Sandhu R, Rivenbark AG, Mackler RM, Livasy CA, Coleman WB. Dysregulation of microrna expression drives aberrant DNA hypermethylation in basal-like breast cancer. Int J Oncol 2014; 44: 563-572.
18. Poudyal D, Cui X, Le PM, Hofseth AB, Windust A, Nagarkatti M, Nagarkatti PS, Schetter AJ, Harris CC, Hofseth LJ. A key role of microrna-29b for the suppression of colon cancer cell migration by american ginseng. PLoS One 2013; 8: e75034.
19. Dai F, Zhang Y, Zhu X, Shan N, Chen Y. The antichemoresistant effect and mechanism of muc1 aptamermir-29b chimera in ovarian cancer. Gynecol Oncol 2013; 131: 451-459.
20. Tan M, Wu J, Cai Y. Suppression of wnt signaling by the mir-29 family is mediated by demethylation of wif-1 in non-small-cell lung cancer. Biochem Biophys Res Commun 2013; 438: 673-679.
21. Yang L, Engeland CG, Cheng B. Social isolation impairs oral palatal wound healing in sprague-dawley rats: A role for mir-29 and mir-203 via vegf suppression. PLoS One 2013; 8: e72359.
22. Zhuang Y, Wei M. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: A meta-analysis. Tumour Biol 2014; 35: 1745-1749.
23. Liu Y, Zheng Q, Wu H, Guo X, Li J, Hao S. Rapamycin increases pcreb, bcl-2, and vegfa through erk under normoxia. Acta Biochim Biophys Sin (Shanghai) 2013; 45: 259-267.
24. Chen D, Zhang YJ, Zhu KW, Wang WC. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma. Tumour Biol 2013; 34: 1895-1899.
25. Li P, Guo W, Du L, Zhao J, Wang Y, Liu L, Hu Y, Hou Y. Microrna-29b contributes to pre-eclampsia through its effects on apoptosis, invasion and angiogenesis of trophoblast cells. Clin Sci (Lond) 2013; 124: 27-40.